By Lisa Simpson, MB, BCh, MPH President and CEO, AcademyHealth Introduction We are only a few weeks into the new…
By Cynthia Boyd, MD, MPH Associate Professor, Johns Hopkins Bloomberg School of Public Health Introduction While the prevalence of having…
Assessing the Evidence Series By Melissa Brouwers, PhD Introduction Practice guidelines are a terrific idea. They provide recommendations, based on…
Assessing the Evidence Series By Pablo Alonso Coello, MD, PhD Introduction Decision-makers do not have an easy job. Several factors…
Assessing the Evidence Series By Philipp Dahm, MD, MHSc On behalf of the U.S. GRADE Network Introduction It is hard…
Assessing the Evidence Series By Eddy Lang, MD Introduction The emergence of evidence-based medicine (EBM) in the 1980s resulted in…
Assessing the Evidence Series By Gordon H. Guyatt, MD, MSc and Jason W. Busse, DC, PhD Risk of Bias: A Better…
Assessing the Evidence Series By Rebecca L Diekemper, MPH, Doctor Evidence, Santa Monica, CA, Belinda K Ireland, MD, MS, TheEvidenceDoc,…
By Craig Whittington, PhD and Jacob Franek, MHSc Introduction GROWTH commentaries started in November 2014, and have covered a broad…
By David Meyers, M.D. Chief Medical Officer, AHRQ Introduction One of my favorite things about attending large conferences is bumping…
By Anna R Gagliardi, PhD Scientist, Toronto General Hospital Research Institute, University Health Network Associate Professor, University of Toronto Chair,…
Changing medical culture and providing care providers and patients with needed information, thereby achieving quality, value, and truly informed consent…
By Sally C. Morton, PhD Professor and Chair, Department of Biostatistics University of Pittsburgh Vice Chair, IOM Committee on Standards for…
By Peg Ford, Co-Founder/President Ovarian Cancer Alliance of San Diego My entry into the world of medical research was due to a…
By Tom Oliver, Director Quality and Guidelines, American Society of Clinical Oncology Introduction The Guideline Program of the American Society of Clinical Oncology (ASCO)…
By Mary P. Nix, MS, PMP Health Scientist Administrator Staff Lead for National Guidelines Clearinghouse and National Quality Measures Clearinghouse Agency for Healthcare Research…
By Sheldon Greenfield, MD, University of California, Irvine, IOM Committee Chair Has the development of clinical practice guidelines (CPGs) made meaningful progress since…
By Marguerite Koster, MA, MFT Chair, Guidelines International Network/North America (G-I-N/NA) Practice Leader, Evidence-Based Medicine Services Unit Kaiser Permanente Southern California When the…
By Sandra Zelman Lewis, PhD, Chief Guidelines Officer, Doctor Evidence The importance of high quality double-blinded randomized controlled trials (RCTs) is…
By Craig W Robbins, MD, MPH, Medical Director, Kaiser Permanente National Guideline Program, Trustee G-I-N Board of Trustees Kaiser Permanente‘s mission is to…
By Craig Whittington, PhD, Associate Director (Clinical Effectiveness), NCCMH, Senior Research Fellow, UCL Director, UK GRADE Centre* We live in interesting times. In…
By Sandra Zelman Lewis, PhD, Chief Guidelines Officer, Doctor Evidence Welcome to the inaugural publication of GROWTH Commentaries! This is a regular…